Glucagon-Like Peptide-1 Receptor Agonist Use Is Not Associated With Increased Complications After Total Hip Arthroplasty in Patients Who Have Type 2 Diabetes
Kevin Heo, Rahul Goel, Alyssa Woltemath, Andrew Fuqua, Bryce T. Hrudka, Omar Syed, Enrique Ramírez de Arellano, Ajay Premkumar, Jacob M. Wilson
Topics & Concepts
AgonistMedicineReceptorTotal hip arthroplastyGlucagon-like peptide-1Diabetes mellitusType 2 diabetesInternal medicineEndocrinologyGlucagon-like peptide 1 receptorArthroplastySurgeryHyperglycemia and glycemic control in critically ill and hospitalized patientsDiabetes Treatment and ManagementBariatric Surgery and Outcomes